TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07383441: Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Sponsor: SWOG Cancer Research Network · Phase: PHASE3 · Area: ONCOLOGY · Target Enrollment: 718 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$2,296,140

Rescue Site Savings

+$1,508,892

Unlock Full NCT07383441 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07383441 Rescue Dossier →